CD8A and systemic sclerosis: The analysis also revealed that, in SSc, ScAFs interact with immune cells via multiple pathways—they can suppress NK- and CD8 T-cell activity via HLA-E, activate macrophages via IL-1β, and activate macrophages and neutrophils via complement pathways (105).